# Loteprednol etabonate and Tobramycin

NDC: 46708-801
Generic name: Loteprednol etabonate and Tobramycin
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20251210

FDA application: ANDA217597

## Active ingredients

- LOTEPREDNOL ETABONATE: 5 mg/mL
- TOBRAMYCIN: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6d68829-f7b6-4b9b-ad44-110c47609918